表紙
市場調査レポート

遺伝子発現分析の世界市場予測 2020年:DNAマイクロアレイ・ポリメラーゼ連鎖反応 (PCR) ・次世代シーケンシング (NGS) ・SAGE法・ノーザンブロッティング法

Gene Expression Analysis Market by Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics) & Applications - Global Forecasts to 2020

発行 MarketsandMarkets 商品コード 296552
出版日 ページ情報 英文 175 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
遺伝子発現分析の世界市場予測 2020年:DNAマイクロアレイ・ポリメラーゼ連鎖反応 (PCR) ・次世代シーケンシング (NGS) ・SAGE法・ノーザンブロッティング法 Gene Expression Analysis Market by Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics) & Applications - Global Forecasts to 2020
出版日: 2016年01月28日 ページ情報: 英文 175 Pages
概要

世界の遺伝子発現分析市場規模は、2015年から2020年にかけて9.3%のCAGRで拡大し、2020年までに53億米ドルに達すると予測されています。安定した資金供給、癌患者数の増加、研究の重視、およびシーケンシングのコスト低下は、遺伝子発現分析市場の成長を促進する主要因となっています。精密医薬 (プレシジョンメディスン) への注目の高まりおよび新興諸国における導入は、同市場へ魅力的な/利益の上がる成長の機会をもたらしています。しかし、特定の高額な装置は市場抑制因子となると同時に、途上諸国における通貨の切り下げは市場の課題を提示しています。

当レポートでは、世界の遺伝子発現市場市場を取り上げ、技術、サービス、アプリケーションおよび地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめ、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の遺伝子発現分析市場概要
  • 地域分析:遺伝子発現分析市場、製品別
  • 遺伝子発現分析市場の地域スナップショット
  • 遺伝子発現分析装置市場規模:技術別

第5章 産業考察

  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • 産業の見解/考察/議論

第6章 市場概要

  • イントロダクション
  • 市場区分
  • 市場ダイナミクス
    • 促進因子
    • 抑制因子
    • 機会
    • 課題

第7章 遺伝子発現分析市場

  • イントロダクション
  • 試薬
  • DNAチップ

第8章 遺伝子発現分析市場:技術別

  • イントロダクション
  • ポリメラーゼ連鎖反応 (PCR)
  • 次世代シーケンシング (NGS)
  • DNAマイクロアレイ
  • その他
    • SERIAL ANALYSIS OF GENE EXPRESSION (SAGE法)
    • ノーザンブロッティング法

第9章 遺伝子発現分析市場:サービス別

  • イントロダクション
  • 遺伝子発現プロファイリングサービス
  • バイオインフォマティクスソリューション

第10章 遺伝子発現分析市場:アプリケーション別

  • イントロダクション
  • 研究
  • 創薬
  • 診断
  • その他

第11章 遺伝子発現市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • その他欧州
  • アジア
    • 中国
    • 日本
    • 韓国、オーストラリア、およびニュージーランド
    • その他のアジア太平洋
  • その他の地域 (ROW)

第12章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第13章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.
  • ILLUMINA, INC.
  • BIO-RAD LABORATORIES, INC.
  • F. HOFFMANN-LA ROCHE LTD. (ROCHE)
  • AGILENT TECHNOLOGIES, INC.
  • AFFYMETRIX, INC.
  • GE HEALTHCARE
  • PERKINELMER, INC.
  • OXFORD GENE TECHNOLOGY

第14章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2236

The global gene expression analysis market is projected to grow at a CAGR of 9.3% from 2015 to 2020 to reach 5.30 billion by 2020. The global gene expression analysis market is expected to witness moderate growth in the coming years. The availability of funding, growth in the number of cancer patients, strong focus on research, and the decreasing cost of sequencing are the major factors driving the growth of the gene expression analysis markets. The increasing focus on precision medicines and adoption amongst emerging countries provides attractive/lucrative growth opportunities for the market. However, the high cost of certain instruments poses as a market restraint while the currency devaluation in developing countries poses as challenge for the market.

In 2015, the services segment is expected to grow at the fastest CAGR from 2015 to 2020 in the global gene expression analysis market, by type. The insights obtained through gene expression profiling play a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years.

In 2015, North America is expected to account for the largest share of the global gene expression analysis market, followed by Europe, Asia, and the Rest of the World (RoW). Asia-Pacific is expected to be the fastest growing regional segment from 2015 to 2020. North America's large share is attributed to development of gene therapy in the U.S., and focus on gene expression studies to improve the quality of patient care. Increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests are the factors expected to augment growth in the Asia-Pacific region.

The market witnesses high competitive intensity, as there are few large players and several small players. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.). are few of the major players in the global gene expression analysis market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned four strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the gene expression analysis market. The report analyzes the gene expression analysis market, by product, services, and by application
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the gene expression analysis market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis markets across regions
  • Competitive Assessment: In-depth assessment of market shares, and strategies of the leading players in the gene expression analysis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. PACKAGE SIZE
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
  • 2.3. KEY DATA FROM SECONDARY SOURCES
    • 2.3.1. PRIMARY RESEARCH
    • 2.3.2. KEY INDUSTRY INSIGHTS
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. KEY INSIGHTS FROM PRIMARY SOURCES
  • 2.6. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.7. MARKET FORECAST METHODOLOGY
  • 2.8. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.9. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL GENE EXPRESSION ANALYSIS MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE GENE EXPRESSION ANALYSIS MARKET
  • 4.4. GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020

5. INDUSTRY INSIGHTS

  • 5.1. VALUE CHAIN ANALYSIS
  • 5.2. PORTER'S FIVE FORCES ANALYSIS
    • 5.2.1. THREAT OF NEW ENTRANTS
    • 5.2.2. THREAT OF SUBSTITUTES
    • 5.2.3. BARGAINING POWER OF BUYERS
    • 5.2.4. BARGAINING POWER OF SUPPLIERS
    • 5.2.5. COMPETITIVE RIVALRY AMONG EXISTING FIRMS
  • 5.3. INDUSTRY VIEWS/INSIGHTS/ INDUSTRY TALKS

6. MARKET OVERVIEW

  • 6.1. INTRODUCTION
  • 6.2. MARKET SEGMENTATION
  • 6.3. MARKET DYNAMICS
    • 6.3.1. DRIVERS
      • 6.3.1.1. Decreasing cost of sequencing
      • 6.3.1.2. Growth in the number of cancer patients
      • 6.3.1.3. Availability of government funding
      • 6.3.1.4. Use of microarray technology to aid gene expression studies
      • 6.3.1.5. SBS technology to aid more detailed cancer studies
      • 6.3.1.6. Availability of gene expression databases
    • 6.3.2. RESTRAINTS
      • 6.3.2.1. High cost of instruments
      • 6.3.2.2. Shortage of trained professionals
    • 6.3.3. OPPORTUNITIES
      • 6.3.3.1. Emerging countries to provide growth opportunities
        • 6.3.3.1.1. Collaborative efforts in China aimed at improving the quality of healthcare
        • 6.3.3.1.2. Strong focus on the biotechnology sector in India
        • 6.3.3.1.3. Government funding for research in Brazil
      • 6.3.3.2. Growing government focus on personalized medicine
    • 6.3.4. CHALLENGE
        • 6.3.4.1.1. Currency Devaluation

7. GENE EXPRESSION ANALYSIS MARKET, BY CONSUMABLES

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS
  • 7.3. DNA CHIPS

8. GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. POLYMERASE CHAIN REACTION (PCR)
  • 8.3. NEXT-GENERATION SEQUENCING (NGS)
    • 8.3.1. COST AND SPEED OF NGS
    • 8.3.2. SUBSTITUTION OF MICROARRAY TECHNOLOGY BY NGS
    • 8.3.3. RESEARCH LABORATORIES AND ACADEMICIANS PROMOTING NGS
    • 8.3.4. GLOBAL ALLIANCES AMONG LEADING RESEARCH INSTITUTES TO ASSIST DRUG DISCOVERY AND INCREASE THE DEMAND FOR NGS
  • 8.4. DNA MICROARRAY
  • 8.5. OTHERS
    • 8.5.1. SERIAL ANALYSIS OF GENE EXPRESSION
    • 8.5.2. NORTHERN BLOTTING

9. GENE EXPRESSION ANALYSIS MARKET, BY SERVICE

  • 9.1. INTRODUCTION
  • 9.2. GENE EXPRESSION PROFILING SERVICES
    • 9.2.1. SEQUENCING SERVICES
    • 9.2.2. OTHER SERVICES
  • 9.3. BIOINFORMATICS SOLUTIONS

10. GENE EXPRESSION ANALYSIS MARKET, BY APPLICATIONS

  • 10.1. INTRODUCTION
  • 10.2. RESEARCH
  • 10.3. DRUG DISCOVERY
  • 10.4. DIAGNOSTICS
  • 10.5. OTHER APPLICATIONS

11. GENE EXPRESSION MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
      • 11.2.1.1. Development of gene therapy in the U.S.
      • 11.2.1.2. Focus on gene expression studies to improve quality of patient care
      • 11.2.1.3. Precision Medicine Initiative
      • 11.2.1.4. Government Funding
    • 11.2.2. CANADA
      • 11.2.2.1. Gene expression profiling tests in Canada
      • 11.2.2.2. Government Initiatives
      • 11.2.2.3. Government funding for NGS
  • 11.3. EUROPE
    • 11.3.1. U.K.
      • 11.3.1.1. U.K. project to sequence 100,000 genomes
      • 11.3.1.2. Government funding in the U.K.
    • 11.3.2. GERMANY
      • 11.3.2.1. Conferences in Germany
    • 11.3.3. FRANCE
      • 11.3.3.1. Introduction of non-invasive prenatal testing in France
    • 11.3.4. REST OF EUROPE (ROE)
      • 11.3.4.1. Turkey to offer growth opportunities
      • 11.3.4.2. Focus on Gene Therapy
      • 11.3.4.3. Increasing funding for molecular diagnostics in Europe
      • 11.3.4.4. Investments in rare disease research
  • 11.4. ASIA PACIFIC
    • 11.4.1. CHINA
      • 11.4.1.1. Western partnerships in China aimed at improving healthcare
      • 11.4.1.2. Domestic manufacturing of sequencing systems in China
      • 11.4.1.3. Efforts of BGI to boost the Chinese market for gene expression
      • 11.4.1.4. Gene expression signature for quality control of traditional Chinese medicines
    • 11.4.2. JAPAN
      • 11.4.2.1. Japanese government's focus on cancer
      • 11.4.2.2. Research efforts in Japan
    • 11.4.3. KOREA, AUSTRALIA, AND NEW ZEALAND
      • 11.4.3.1. Need to develop treatments for animals
      • 11.4.3.2. Flourishing bioresearch centers & financial support in Australia
    • 11.4.4. REST OF ASIA-PACIFIC (ROAPAC)
      • 11.4.4.1. Gene expression tests gaining popularity in India
      • 11.4.4.2. The rise of the Indian gene expression analysis market
      • 11.4.4.3. Regular funding from the Indian government, an impetus to the NGS market
      • 11.4.4.4. Singapore's strong focus on neurodegenerative diseases
  • 11.5. REST OF THE WORLD (ROW)
      • 11.5.1.1. Sequencing of 100,000 Genomes in the Saudi Arabia
      • 11.5.1.2. Focus on HIV/AIDS genetic research in Africa
      • 11.5.1.3. South American countries focus on genomic research to improve public health
      • 11.5.1.4. Bioinformatics & biotechnology research in Latin America to boost the demand for NGS instruments & services

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
    • 12.2.1. THERMO FISHER SCIENTIFIC
    • 12.2.2. ILLUMINA, INC.
    • 12.2.3. BIO-RAD LABORATORIES
    • 12.2.4. QIAGEN N.V.
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. NEW PRODUCT LAUNCHES
    • 12.3.2. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
    • 12.3.3. ACQUISITIONS
    • 12.3.4. OTHER STRATEGIES

13. COMPANY PROFILES*

  • 13.1. INTRODUCTION
  • 13.2. THERMO FISHER SCIENTIFIC, INC.
  • 13.3. QIAGEN N.V.
  • 13.4. ILLUMINA, INC.
  • 13.5. BIO-RAD LABORATORIES, INC.
  • 13.6. F. HOFFMANN-LA ROCHE LTD. (ROCHE)
  • 13.7. AGILENT TECHNOLOGIES, INC.
  • 13.8. AFFYMETRIX, INC.
  • 13.9. GE HEALTHCARE
  • 13.10. PERKINELMER, INC.
  • 13.11. OXFORD GENE TECHNOLOGY

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. COMPANY DEVELOPMENTS (2013-2015)
    • 14.2.1. THERMO FISHER SCIENTIFIC, INC.
    • 14.2.2. QIAGEN N.V.
    • 14.2.3. ILLUMINA INC.
    • 14.2.4. ROCHE
    • 14.2.5. BIO-RAD LABORATORIES
    • 14.2.6. AGILENT TECHNOLOGIES, INC.
    • 14.2.7. AFFYMETRIX
    • 14.2.8. GE HEALTHCARE
    • 14.2.9. PERKINELMER, INC.
    • 14.2.10. OXFORD GENE TECHNOLOGY
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: THE DECREASING COST OF SEQUENCING WILL ACT AS A MAJOR DRIVER FOR THE MARKET
  • TABLE 2: HIGH COST OF INSTRUMENTS IS A MAJOR FACTOR RESTRAINING MARKET GROWTH
  • TABLE 3: EMERGING COUNTRIES TO PROVIDE GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • TABLE 4: CURRENCY DEVALUATION POSES AS A CHALLENGE FOR THE MARKET GROWTH
  • TABLE 5: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION)
  • TABLE 6: GENE EXPRESSION ANALYSIS CONSUMABLES MARKET SIZE, BY REGION, 2013-2020 (USD) MILLION
  • TABLE 7: NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION)
  • TABLE 8: EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION)
  • TABLE 9: ASIA-PACIFIC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION)
  • TABLE 10: ROW: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION)
  • TABLE 11: GENE EXPRESSION ANALYSIS REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 14: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 15: GENE EXPRESSION ANALYSIS TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: GENE EXPRESSION ANALYSIS MARKET SIZE FOR PCR, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: GENE EXPRESSION ANALYSIS MARKET SIZE FOR NGS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: GENE EXPRESSION ANALYSIS MARKET SIZE FOR DNA MICROARRAY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: OTHER GENE EXPRESSION ANALYSIS TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 21: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 23: EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 24: ASIA-PACIFIC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 25: ROW: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 26: GENE EXPRESSION PROFILING SERVICES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: GENE EXPRESSION PROFILING SERVICES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 28: SEQUENCING SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: OTHER SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: BIOINFORMATICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 32: GENE EXPRESSION ANALYSIS APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: GENE EXPRESSION ANALYSIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: GENE EXPRESSION ANALYSIS MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: GENE EXPRESSION ANALYSIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: GENE EXPRESSION ANALYSIS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 41: U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 43: U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 45: CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 49: EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 51: EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 53: U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 54: U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: ROE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ROE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: ROE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: ROE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 69: APAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: APAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 71: APAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: APAC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 73: CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 74: CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 75: CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 76: CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 77: JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 78: JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 79: JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 80: JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 81: KANZ: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 82: KANZ: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 83: KANZ: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 84: KANZ GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 85: ROAPAC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 86: ROAPAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 87: ROAPAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 88: ROAPAC GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 89: ROW: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 90: ROW: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 91: ROW: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 92: ROW: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 93: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 94: COLLABORATIONS, AGREEMENTS, PARTNERSHIPS, 2012-2015
  • TABLE 95: ACQUISITIONS, 2012-2015
  • TABLE 96: OTHER STRATEGIES, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL GENE EXPRESSION ANALYSIS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GENE EXPRESSION ANALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: STRONG FOCUS ON RESEARCH & DECREASING COST OF SEQUENCING-MAJOR DRIVERS FOR THE GENE EXPRESSION ANALYSIS MARKET
  • FIGURE 13: NORTH AMERICA AND RESEARCH SEGMENT DOMINATES THE GENE EXPRESSION ANALYSIS MARKET IN 2015
  • FIGURE 14: ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: NGS SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020
  • FIGURE 16: VALUE CHAIN FOR SEQUENCING PLATFORMS
  • FIGURE 17: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 18: GENE EXPRESSION ANALYSIS: MARKET SEGMENTATION
  • FIGURE 19: GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE
  • FIGURE 20: BIOCON LTD.: ANNUAL REVENUES, 2010-2014 (USD MILLION)
  • FIGURE 21: REAGENTS DOMINATE THE GENE EXPRESSION CONSUMABLES MARKET
  • FIGURE 22: PCR SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2015
  • FIGURE 23: GENE EXPRESSION PROFILING SERVICES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 24: RESEARCH SEGMENT TO DOMINATE THE GENE EXPRESSION ANALYSIS MARKET IN 2015
  • FIGURE 25: NORTH AMERICA DOMINATES THE GLOBAL GENE EXPRESSION ANALYSIS MARKET IN 2015
  • FIGURE 26: U.S. HOLDS HIGHEST SHARE OF THE NORTH AMERICAN GENE EXPRESSION ANALYSIS MARKET IN 2015
  • FIGURE 27: U.K. HOLDS LARGEST SHARE OF THE EUROPEAN MARKET FOR GENE EXPRESSION ANALYSIS
  • FIGURE 28: CHINA IS EXPECTED TO DOMINATE THE ASIA-PACIFIC MARKET
  • FIGURE 29: ROW REGION IS EXPECTED TO WITNESS SLOW GROWTH IN THE GENE EXPRESSION ANALYSIS MARKET
  • FIGURE 30: NEW PRODUCT LAUNCH WAS THE MAJOR GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 31: GLOBAL GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 32: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY (2012-2015)
  • FIGURE 33: GEOGRAPHIC REVENUE MIX OF THE MAJOR PLAYERS
  • FIGURE 34: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 35: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 36: ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 37: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 38: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 39: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 40: AFFYMETRIX, INC.: COMPANY SNAPSHOT
  • FIGURE 41: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 42: PERKINELMER, INC.: COMPANY SNAPSHOT
Back to Top